Evidence map›Paper›PMID 38575161›Full record

ArticleThe European respiratory journal2024

Symptoms before and after COVID-19: a population and case-control study using prospective data.

Carole H Sudre, Michela Antonelli, Nathan J Cheetham, Erika Molteni, Liane S Canas, Vicky Bowyer, Ben Murray, Khaled Rjoob, Marc Modat, Joan Capdevila Pujol and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The European respiratory journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Carole H SudreSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Michela AntonelliSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Nathan J CheethamDepartment of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King's College London, London, UK.
Erika MolteniSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Liane S CanasSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Vicky BowyerDepartment of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King's College London, London, UK.
Ben MurraySchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Khaled RjoobMRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science and Experimental Medicine, University College London, London, UK.
Marc ModatSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Joan Capdevila PujolZOE Limited London, London, UK.
Christina HuZOE Limited London, London, UK.
Jonathan WolfZOE Limited London, London, UK.
Tim D SpectorDepartment of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King's College London, London, UK.
Alexander HammersSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Claire J StevesDepartment of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King's College London, London, UK.
Sebastien OurselinSchool of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Emma L DuncanDepartment of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King's College London, London, UK emma.duncan@kcl.ac.uk.

Funding

Medical Research Council MC_PC_20051Wellcome Trust
6 · The paper itself

Abstract

backgroundSome individuals experience prolonged illness after acute coronavirus disease 2019 (COVID-19). We assessed whether pre-infection symptoms affected post-acute COVID illness duration.

methodsSurvival analysis was performed in adults (n=23 452) with community-managed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection prospectively self-logging data through the ZOE COVID Symptom Study app, at least weekly, from 8 weeks before to 12 weeks after COVID-19 onset, conditioned on presence

resultsIndividuals reporting baseline symptoms had longer COVID-related symptom duration (median 15 days

conclusionsIndividuals experiencing symptoms before COVID-19 had longer illness duration and increased odds of long illness. However, many individuals with long illness were well before SARS-CoV-2 infection.

Indexed as

COVID-19SARS-CoV-2AdultAgedCase-Control StudiesFatigueFemaleHumansMaleMiddle AgedPost-Acute COVID-19 SyndromeProspective StudiesSurvival AnalysisTime Factors

Identifiers

PMID38575161
PMCPMC11255388

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.